Related Experiment Video
Updated: May 8, 2026

Robotic Ablation of Atrial Fibrillation
Published on: May 29, 2015
Automated regional citrate anticoagulation system based on individualized dosing models in nonliver failure patients
Qi Zhang1, Damin Ding2, Chaobin Wang2
1Division of Nephrology, Shanghai Ninth People's Hospital, School of Medicine, Shanghai Jiaotong University, Shanghai, China.
Insights
This study introduces an automated system for regional citrate anticoagulation during renal replacement therapy. The system personalizes calcium levels, ensuring safe and effective treatment for critically ill patients.
Area of Science:
- Nephrology
- Critical Care Medicine
- Biomedical Engineering
Background:
- Regional citrate anticoagulation (RCA) is crucial for renal replacement therapy (RRT) in critically ill patients.
- Current RCA methods often overlook individual variations in ionized calcium levels.
- This limitation can impact treatment efficacy and safety.
Purpose of the Study:
- To evaluate the safety and efficacy of the SuperbMed® RCA-SP100, an automated RCA system.
- The system utilizes individualized citrate and calcium supplementation models.
- The study focused on its application in prolonged intermittent renal replacement therapy (PIHHT).
Main Methods:
- Seven patients undergoing PIHHT were treated with the SuperbMed® RCA-SP100 system.
- Ionized calcium levels were monitored hourly, both *in vivo* and *in vitro*.
- Pump accuracy and alarm sensitivity were assessed.
Main Results:
- The system maintained extracorporeal ionized calcium levels at 0.34 ± 0.02 mmol/L and *in vivo* levels at 1.09 ± 0.07 mmol/L.
- No patient interventions or filter coagulations were reported.
- Pump accuracy was within 5%, with precise alarm triggering.
Conclusions:
- The SuperbMed® RCA-SP100 system enables precise and secure regional citrate anticoagulation.
- Individualized calcium supplementation enhances treatment safety and efficacy in PIHHT.
- This automated system represents a significant advancement in RRT for critical care.
Introduction:
Regional citrate anticoagulation is a preferred option for renal replacement therapy in critically ill patients. However, current implementations ignore individual differences that may exist in the fluctuation of patients' ionized calcium levels. To address this problem, individualized citrate and calcium supplementation models were established based on the pharmacokinetic and clearance characteristics of citrate, and an automated regional citrate anticoagulation system was built with these models as its core to facilitate the treatment of clinical patients. This study was designed to preliminarily evaluate the safety and efficacy of this system, the SuperbMed® RCA-SP100 automated regional citrate anticoagulation system, in prolonged intermittent renal replacement therapy.
Methods:
Seven patients undergoing prolonged intermittent renal replacement therapy completed treatment with the SuperbMed® RCA-SP100 system. In vivo and in vitro ionized calcium levels were measured every hour before and after the start of dialysis. The accuracy and alarm sensitivity of the pumps were also monitored.
Results:
During seven treatments, the average extracorporeal ionized calcium level was 0.34 ± 0.02 mmol/L, and the mean ionized calcium level in vivo was 1.09 ± 0.07 mmol/L. No patient required intervention, and there was no filter coagulation. The pumps all had an absolute accuracy less than 5%, and alarms could be triggered precisely.
Conclusions:
We reported on an automated system that allows for individualized citrate and calcium supplementation in prolonged intermittent renal replacement therapy and enables the precise and secure implementation of regional citrate anticoagulation.
Related Concept Videos
Extracorporeal Removal of Drugs: Continuous Renal Replacement Therapy
Impact of Pharmacokinetic–Pharmacodynamic Models: Regulatory Decisions
Peripheral Artery Disease III: Interprofessional Care
Venous Thrombosis III: Interprofessional Care
Continuous Renal Replacement Therapy

